Drug Drug Interaction Clinical Trials

Assessing risks. Proper use.

As required by regulatory agencies, how an investigational drug is metabolized needs to be defined during early phase drug development and that its interaction with other drugs needs to be explored as part of an adequate assessment of safety and effectiveness. inVentiv Health Clinical professionals have the experience to evaluate the safety profile of the compound under co-administration regimes while ensuring the well-being of study participants.

Because not every drug interaction is metabolism-based but may arise from changes in pharmacokinetics caused by absorption, distribution, and excretion interactions, inVentiv Health Clinical offers a full range of drug interaction studies including the evaluation of pharmacodynamic effects.

inVentiv Health's clinical specialists provide the scientific-based and regulatory-compliant solutions you need. It’s just another way inVentiv Health Clinical works with you.

Phase I-IIa Brochure